Highlights
- Hester Biosciences Limited (NSE: HESTERBIO) surged over 16% during Monday's trading session.
- The stock touched an intraday high of ₹2,478.60 after opening at ₹2,110.00.
- The company reported healthy profitability in its latest quarterly results.
- Shares traded well above the 50-day moving average, indicating sustained strength.
- Trading volumes rose significantly alongside the sharp price advance.
- Momentum indicators reflected improving market participation and positive price action.
Overview
Hester Biosciences Limited (NSE: HESTERBIO), a leading animal healthcare company engaged in manufacturing vaccines and health products for poultry and livestock, witnessed strong buying momentum during Monday's trading session. The stock climbed over 16% to trade around ₹2,473.70 after touching an intraday high of ₹2,478.60, compared with the previous close of ₹2,120.90. The sharp rally placed the stock among the top gainers on the NSE, supported by healthy quarterly earnings and improving market sentiment.
Fundamental View
For the quarter ended 31 March 2026, Hester Biosciences reported standalone total income of ₹9,789.20 lakh. Profit before tax stood at ₹3,487.00 lakh, while net profit came in at ₹2,638.40 lakh. The company reported earnings per share (EPS) of ₹31.01, reflecting a profitable quarter supported by stable business operations. The latest financial performance indicates healthy earnings generation, while investors are likely to monitor future demand for veterinary vaccines, expansion initiatives, and margin sustainability.
Technical View
The stock witnessed a strong breakout after opening at ₹2,110.00 and quickly moved to an intraday high of ₹2,478.60. It continued trading well above its 50-day simple moving average of ₹1,972.12, reflecting a strengthening medium-term trend. The 14-day Relative Strength Index (RSI) moved to around 74.17, indicating strong momentum following the sharp rally. Higher trading volumes during the session further highlighted increased market participation.
Key Technical Levels
Immediate support is placed near ₹2,320.00, while the next important support is seen around ₹2,180.00. On the upside, immediate resistance is located near ₹2,480.00, and a sustained move above this level could shift attention towards the ₹2,600.00 zone.
Risks to Watch
- Volatility following a sharp one-day rally.
- Demand fluctuations in the animal healthcare sector.
- Raw material cost movements affecting margins.
- Regulatory developments related to veterinary healthcare products.
- Overall market sentiment and broader equity market volatility.
Summary
Hester Biosciences Limited (NSE: HESTERBIO) emerged among the top NSE gainers after delivering a strong double-digit rally backed by healthy quarterly earnings and improving technical momentum. The stock continues to trade above key moving averages with robust participation, while investors may closely watch future financial performance, business expansion, and the stock's ability to sustain the recent breakout.
FAQs
Q: Why did Hester Biosciences Limited (NSE: HESTERBIO) stock rise today?
A: The stock gained more than 16% following healthy quarterly earnings, improving technical momentum, and strong trading activity.
Q: What was the latest traded price of Hester Biosciences Limited (NSE: HESTERBIO)?
A: The stock traded around ₹2,473.70 after touching an intraday high of ₹2,478.60.
Q: How were Hester Biosciences' latest quarterly results?
A: The company reported standalone total income of ₹9,789.20 lakh, net profit of ₹2,638.40 lakh, and EPS of ₹31.01 for the quarter ended 31 March 2026.
Q: What does the current technical setup indicate?
A: The stock is trading above its 50-day moving average with strong momentum and higher-than-average trading volumes.
Q: What should investors monitor going forward?
A: Investors may track future earnings performance, demand trends in the animal healthcare business, margin sustainability, and whether the stock maintains its recent upward momentum.